查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631548

子宮肌瘤治療設備市場規模、佔有率、趨勢分析報告：按技術、治療模式、地區和細分市場進行預測，2025-2030 年

Uterine Fibroids Treatment Devices Market Size, Share & Trends Analysis Report By Technology (Surgical Techniques, Laparoscopic Techniques), By Mode Of Treatment, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

子宮肌瘤治療設備市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球子宮肌瘤治療設備市場預計到2030年將達到121億美元，預計2025年至2030年期間的複合年成長率為9.4%。

子宮肌瘤患者數量的增加以及對子宮肌瘤診斷和治療相關認知的不斷提高正在推動市場的發展。

用於治療子宮肌瘤（UF）的微創和非侵入性手術由於相關風險的降低而越來越受歡迎。小切口可減輕術後疼痛並促進快速恢復，因此此類手術的採用率很高，並激發了該領域研究和開發的成長。許多主要企業正在投入研發，推出創新的微創和非侵入性手術器材。

此外，預計在預測期內，多項宣傳宣傳活動、新產品發布以及市場參與企業採用的新技術將推動市場成長。例如，像 Merit Medical 這樣的公司不僅致力於傳播有關子宮肌瘤的認知，還致力於教育人們了解安全有效的手術替代方案。他們還提供 Ask4UFE 患者教育計劃，其中包括資訊圖表、小冊子、月度報導和時事通訊，基於子宮肌瘤和子宮肌瘤栓塞 (UFE) 的益處。

子宮肌瘤治療設備市場報告重點：

  • 由於女性子宮肌瘤盛行率不斷上升，導致需要有效的手術干預，因此手術技術部門在 2024 年佔據了市場主導地位，收益佔有率為 34.0%。
  • 預測期內，消融技術部門預計以最高的複合年成長率成長 10.4%。
  • 由於侵入性治療在治療嚴重子宮肌瘤方面已得到證實有效，2024 年侵入性治療領域佔據了市場主導地位，收益佔有率最大。
  • 2024 年北美子宮肌瘤治療設備市場佔據全球市場主導地位，收益佔有率為 48.2%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章子宮肌瘤治療設備市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第 4 章子宮肌瘤治療設備市場：技術業務分析

  • 2024 年及 2030 年技術市場佔有率
  • 技術細分儀表板
  • 2018 - 2030 年市場規模、預測與趨勢分析（按技術分類）
  • 手術技術
  • 腹腔鏡技術
  • 消融技術
  • 栓塞

第5章子宮肌瘤治療設備市場：治療模式商業分析

  • 治療模式市場佔有率，2024 年和 2030 年
  • 治療模式細分儀表板
  • 2018 年至 2030 年按治療模式分類的市場規模、預測與趨勢分析
  • 侵入性治療
  • 微創治療
  • 非侵入性治療

第6章子宮肌瘤治療設備市場：按地區估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018 年至 2030 年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Insightec.
    • CooperSurgical Inc.
    • Hologic, Inc.
    • Lumenis Be Ltd
    • CONMED Corporation.
    • Gynesonics
    • Merit Medical Systems.
Product Code: GVR-4-68038-820-6

Uterine Fibroids Treatment Devices Market Growth & Trends:

The global uterine fibroids treatment devices market size is estimated to reach USD 12.1 billion by 2030, registering to grow at a CAGR of 9.4% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing population of uterine fibroids patients and rising awareness initiatives related to fibroids diagnosis and treatment are driving the market.

Minimally invasive and non-invasive surgeries for the treatment of Uterine Fibroids (UF) are gaining popularity owing to the reduced risk associated with these procedures. Smaller incisions decrease post-operative pain and facilitate speedy recovery, thus leading to high adoption of these procedures and triggering the growth of R&D in this field. Many key players are investing in research and development for the launch of innovative minimally and non-invasive surgical instruments.

Furthermore, several awareness campaigns, new product launches, and incorporation of new technologies by market players are expected to fuel the market growth during the forecast period. For instance, companies such as Merit Medical are dedicated to spreading fibroid awareness as well as promoting a safe and effective alternative to surgery. They also provide Ask4UFE patient educational programs, such as infographics, brochures, monthly articles, and newsletters, based on uterine fibroids and the benefits of uterine fibroid embolization (UFE).

Uterine Fibroids Treatment Devices Market Report Highlights:

  • The surgical techniques segment dominated the market with a revenue share of 34.0% in 2024, attributed to the increasing prevalence of uterine fibroids among women, necessitating effective surgical interventions.
  • The ablation techniques segment is projected to grow at the highest CAGR of 10.4% over the forecast period.
  • The invasive treatment segment dominated the market with the largest revenue share in 2024, attributed to its established efficacy in treating severe uterine fibroids.
  • North America uterine fibroids treatment devices market dominated the global market, with a revenue share of 48.2% in 2024, driven by high healthcare spending and advanced medical infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Mode of Treatment
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Uterine Fibroids Treatment Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Uterine Fibroids Treatment Devices Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
  • 4.4. Surgical Techniques
    • 4.4.1. Surgical Techniques Market, 2018 - 2030 (USD Billion)
    • 4.4.2. Hysterectomy
      • 4.4.2.1. Hysterectomy Market, 2018 - 2030 (USD Billion)
    • 4.4.3. Myomectomy
      • 4.4.3.1. Myomectomy Market, 2018 - 2030 (USD Billion)
  • 4.5. Laparoscopic Techniques
    • 4.5.1. Laparoscopic Techniques Market, 2018 - 2030 (USD Billion)
    • 4.5.2. Laparoscopic Myotectomy
      • 4.5.2.1. Laparoscopic Myotectomy Market, 2018 - 2030 (USD Billion)
    • 4.5.3. Myolysis
      • 4.5.3.1. Myolysis Market, 2018 - 2030 (USD Billion)
  • 4.6. Ablation Techniques
    • 4.6.1. Ablation Techniques Market, 2018 - 2030 (USD Billion)
    • 4.6.2. Microwave Ablation
      • 4.6.2.1. Microwave Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.3. Hydrothermal Ablation
      • 4.6.3.1. Hydrothermal Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.4. Cryoablation
      • 4.6.4.1. Cryoablation, 2018 - 2030 (USD Billion)
    • 4.6.5. Ultrasound Ablation
      • 4.6.5.1. Ultrasound Ablation Market, 2018 - 2030 (USD Billion)
      • 4.6.5.2. High Intensity Focused Ultrasound (HIFU)
        • 4.6.5.2.1. High Intensity Focused Ultrasound (HIFU) Market, 2018 - 2030 (USD Billion)
      • 4.6.5.3. MRI-guided Focused Ultrasound (MRgFUS)
        • 4.6.5.3.1. MRI-guided Focused Ultrasound (MRgFUS) Market, 2018 - 2030 (USD Billion)
  • 4.7. Embolization Techniques
    • 4.7.1. Embolization Techniques Market, 2018 - 2030 (USD Billion)

Chapter 5. Uterine Fibroids Treatment Devices Market: Mode of Treatment Business Analysis

  • 5.1. Mode of Treatment Market Share, 2024 & 2030
  • 5.2. Mode of Treatment Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Mode of Treatment, 2018 to 2030 (USD Billion)
  • 5.4. Invasive Treatment
    • 5.4.1. Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.5. Minimally Invasive Treatment
    • 5.5.1. Minimally Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.6. Non-invasive Treatment
    • 5.6.1. Non-invasive Treatment Market, 2018 - 2030 (USD Billion)

Chapter 6. Uterine Fibroids Treatment Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.5.10. Russia
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Regulatory Framework
      • 6.5.10.3. Competitive Insights
      • 6.5.10.4. Russia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework
      • 6.7.4.3. Competitive Insights
      • 6.7.4.4. Colombia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Medtronic
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Technology Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Stryker
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Technology Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Boston Scientific Corporation
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Technology Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Insightec.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Technology Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. CooperSurgical Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Technology Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hologic, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Technology Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Lumenis Be Ltd
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Technology Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. CONMED Corporation.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Technology Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Gynesonics
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Technology Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Merit Medical Systems.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Technology Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global uterine fibroids treatment devices market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 5 Global uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 6 North America uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 8 North America uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 9 U.S. uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 10 U.S. uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 11 Canada uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 12 Canada uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 13 Mexico uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 14 Mexico uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 15 Europe uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 17 Europe uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 18 UK uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 19 UK uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 20 Germany uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 21 Germany uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 22 France uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 23 France uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 24 Italy uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 25 Italy uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 26 Spain uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 27 Spain uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 28 Norway uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 29 Norway uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 30 Denmark uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 31 Denmark uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 32 Sweden uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 33 Sweden uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 34 Russia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 35 Russia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 37 Asia Pacific uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 39 Japan uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 40 Japan uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 41 China uterine fibroids treatment devices market, by technology, 2018-2030 (USD Billion)
  • Table 42 China uterine fibroids treatment devices market, by mode of treatment, 2018-2030 (USD Billion)
  • Table 43 India uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 44 India uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 45 Australia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 46 Australia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 47 South Korea uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 48 South Korea uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 49 Thailand uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 50 Thailand uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 51 Latin America uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 52 Latin America uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 53 Latin America uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 54 Brazil uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 55 Brazil uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 56 Argentina uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 57 Argentina uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 58 Colombia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 59 Colombia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 62 Middle East & Africa uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 63 South Africa uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 64 South Africa uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 65 Saudi Arabia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 66 Saudi Arabia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 67 UAE uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 68 UAE uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 69 Kuwait uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 70 Kuwait uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Uterine fibroids treatment devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology outlook (USD Billion)
  • Fig. 10 Mode of treatment outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Uterine fibroids treatment devices market dynamics
  • Fig. 13 Uterine fibroids treatment devices market: Porter's five forces analysis
  • Fig. 14 Uterine fibroids treatment devices market: PESTLE analysis
  • Fig. 15 Uterine fibroids treatment devices market: Technology segment dashboard
  • Fig. 16 Uterine fibroids treatment devices market: Technology market share analysis, 2024 & 2030
  • Fig. 17 Surgical techniques market, 2018 - 2030 (USD Billion)
  • Fig. 18 Hysterectomy market, 2018 - 2030 (USD Billion)
  • Fig. 19 Myomectomy market, 2018 - 2030 (USD Billion)
  • Fig. 20 Laparoscopic techniques market, 2018 - 2030 (USD Billion)
  • Fig. 21 Laparoscopic myomectomy market, 2018 - 2030 (USD Billion)
  • Fig. 22 Myolysis market, 2018 - 2030 (USD Billion)
  • Fig. 23 Ablation techniques market, 2018 - 2030 (USD Billion)
  • Fig. 24 Microwave ablation market, 2018 - 2030 (USD Billion)
  • Fig. 25 Hydrothermal ablation market, 2018 - 2030 (USD Billion)
  • Fig. 26 Cryoablation market, 2018 - 2030 (USD Billion)
  • Fig. 27 Ultrasound ablation market, 2018 - 2030 (USD Billion)
  • Fig. 28 High intensity focused ultrasound (HIFU) market, 2018 - 2030 (USD Billion)
  • Fig. 29 MRI-guided focused ultrasound (MRgFUS) market, 2018 - 2030 (USD Billion)
  • Fig. 30 Embolization techniques market, 2018 - 2030 (USD Billion)
  • Fig. 31 Uterine fibroids treatment devices market: Mode of treatment segment dashboard
  • Fig. 32 Uterine fibroids treatment devices market: Mode of treatment market share analysis, 2024 & 2030
  • Fig. 33 Invasive treatment market, 2018 - 2030 (USD Billion)
  • Fig. 34 Minimally invasive treatment market, 2018 - 2030 (USD Billion)
  • Fig. 35 Non-invasive Treatment market, 2018 - 2030 (USD Billion)
  • Fig. 36 Uterine fibroids treatment devices market revenue, by region
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 45 Europe uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 50 France country dynamics
  • Fig. 51 France uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 58 Denmark country dynamics
  • Fig. 59 Denmark uterine fibroids treatment devices market, 2018 - 2030 (USD Billion
  • Fig. 60 Sweden country dynamics
  • Fig. 61 Sweden uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 62 Russia country dynamics
  • Fig. 63 Russia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 64 Asia Pacific uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 65 Japan country dynamics
  • Fig. 66 Japan uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 67 China country dynamics
  • Fig. 68 China uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 69 India country dynamics
  • Fig. 70 India uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Korea country dynamics
  • Fig. 72 South Korea uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 73 Australia country dynamics
  • Fig. 74 Australia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 75 Thailand country dynamics
  • Fig. 76 Thailand uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 77 Latin America uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 78 Brazil country dynamics
  • Fig. 79 Brazil uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 80 Argentina country dynamics
  • Fig. 81 Argentina uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 82 Colombia country dynamics
  • Fig. 83 Colombia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 84 MEA uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 85 South Africa country dynamics
  • Fig. 86 South Africa uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 87 Saudi Arabia country dynamics
  • Fig. 88 Saudi Arabia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 89 UAE country dynamics
  • Fig. 90 UAE uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 91 Kuwait country dynamics
  • Fig. 92 Kuwait uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 93 Company categorization
  • Fig. 94 Company market position analysis
  • Fig. 95 Strategic framework